Already a DIA Member? Sign in. Not a member? Join.

Sign in

Forgot User ID? or Forgot Password?

Not a Member?

Create Account and Join

Virtual Event

Oct 06, 2020 10:00 AM - Oct 07, 2020 5:25 PM

(US Eastern Standard Time)

Fort Washington, PA 19034

Biosimilars Conference

Session 6: Growing Clinical Use and Experience: What Can be Learned From Key International Initiatives?

Session Chair(s)

Julie  Marechal-Jamil, MSc

Julie Marechal-Jamil, MSc

Director, Biosimilar Policy and Science

Medicines For Europe, Belgium

Jian  Wang, MD, PhD

Jian Wang, MD, PhD

Division Manager, Clinical Review Division – Heamatology/Oncology

Health Canada, Canada

Biosimilar medicines have been available globally for nearly 14 years. As they entered various regions and countries, policy makers, healthcare community stakeholders have devised different ways to introduce these medicines in the medical practice, grow the use of biosimilar medicines and enhance care for patients. The experience and confidence in biosimilar medicines keeps expanding, yet at different pace and rate depending on geographies. In this session, 3 initiatives (from outside the U.S.) supporting biosimilar uptake and clinical use will be presented followed by a discussion on the learnings, including key principles and key enablers.

Learning Objective : At the conclusion of this session, participants should be able to:
  • Share concrete examples of conducive biosimilar policy measures
  • Inspire creative approaches to deliver broad healthcare benefits from biosimilar use
  • Emulate experience sharing as driver towards policy implementation

Speaker(s)

Scott  Gavura, MBA, RPh

The pan-Canadian Oncology Biosimilar Initiative: Building Confidence Through Engagement and Education

Scott Gavura, MBA, RPh

Ontario Health (Cancer Care Ontario), Canada

Director of Provincial Drug Reimbursement Programs

Blake  Dark

UK Lessons Learned from Multi-Winner Tenders

Blake Dark

NHS, England, United Kingdom

Commercial Medicines Director

Etienne  Nedellec, PharmD, MSc

France National Health Strategy and Biosimilar Pilot Sharing Scheme

Etienne Nedellec, PharmD, MSc

Ministry of Social Affairs and Health, France

French National Health Care Directorate

Have an account?

Be informed and stay engaged.

Don't miss an opportunity - join our mailing list to stay up to date on DIA insights and events.